Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

This Busted “Blockbuster” Still Has Potential

This Busted "Blockbuster" Still Has Potential

Biotech ARIAD Pharmaceuticals Inc. (Nasdaq: ARIA) had to halt clinical-trial enrollment on its blockbuster leukemia drug Iclusig after investigators tracked a rising rate of blood clots among patients receiving the therapy.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK